The Fund aims to achieve above average capital growth.
Name | % Net Assets |
---|---|
DIRECTV Group Inc. | 8.0% |
Oracle Corp. | 3.8% |
JPMorgan Chase & Co. | 3.6% |
Wells Fargo & Co. | 3.4% |
UnitedHealth Group Inc. | 3.0% |
DaVita Inc. | 3.0% |
Pfizer Inc. | 3.0% |
Airgas Inc. | 2.9% |
Crown Castle International Corp. | 2.5% |
Amgen Inc. | 2.5% |
Key | % Net Assets |
---|---|
DIRECTV Group Inc. | 8.0% |
Oracle Corp. | 3.8% |
JPMorgan Chase & Co. | 3.6% |
Wells Fargo & Co. | 3.4% |
Other | 81.2% |
Date | 18-Apr-2024 |
---|---|
NAV | 577.74p |
Currency | GBP |
Change | -7.45p |
% | -1.27% |
YTD change | 39.69p |
YTD % | 7.38% |
Fund Inception | 31/03/1982 |
---|---|
Fund Manager | Cormac Weldon |
TER | 1.67 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.04 |
You are here: research